Share

FDA's CTP Regulation of Tobacco Products: Modified Risk Claims

November 11, 2026

The Family Smoking Prevention and Tobacco Control Act (TCA) prohibits tobacco manufacturers from using misleading descriptors about their products and requires a substantive scientific review by the Food and Drug Administration's Center for Tobacco Products prior to using any "modified risk" claim. This is one of the most important provisions of the TCA as it directly addresses the tobacco industry's deceptive marketing practices about the harm of its products.